Filgrastim Completed Phase 1 Trials for Neuroblastomas / Retinoblastoma / Brain and Central Nervous System Tumors / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00053118Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer